Zdrowie i gospodarka · 09/08/2024
FDA Releases Revised Draft Guidance for Nonmuscle Invasive Bladder Cancer Treatment
The FDA has released a revised draft guidance for the development of treatments for nonmuscle invasive bladder cancer patients who have not responded to BCG therapy, incorporating feedback from experts and updates in bladder cancer drug development.
Source: Federal Register — Food and Drug AdministrationOpen original release →